Open AccessTransurethral Resection Of En-Bloс Muscularis Non - Invasive Bladder Cancer
Author(s) -
Mirzagaleb Nigmatovich Tillashayhov,
E.V. Boyko,
Ravshan Abdurasulovich Khashimov,
Nodir Mahammatkulovich Rakhimov
Publication year - 2021
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume03issue06-13
Subject(s) - medicine , bladder cancer , urology , resection , cancer , surgery
The high recurrence rate of muscle noninvasive bladder cancer (BC) dictates the search for new methods of surgical treatment. The problem of bladder cancer (BC) treatment is very urgent in urology, because of high morbidity, difficulties in determining the optimal treatment tactics, necessity of long-term follow-up examinations, high recurrence rate and progression. Risk and progression criteria have been developed to identify groups of patients in need of closer follow-up, which can be quantified using risk calculators for recurrence and tumour progression. Although there are clear guidelines for the treatment of patients with bladder cancer, it is also believed that the rate of recurrence depends on the quality of the primary surgical procedure performed [1,2].